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Abstract
The evidence that severe acute pancreatitis can result in critical
illness-related corticosteroid insufficiency following impaired adrenal
secretion is accumulating. The study by Peng and coworkers in
Critical Care certainly contributes to that idea, even though the
question whether relative adrenal insufficiency should prompt for
treatment by substitution doses of corticosteroids remains
unresolved. The study is discussed in terms of the risk factors,
circumstances and significance of impaired corticosteroid secre-
tion by adrenals in severe acute pancreatitis.
In a recent issue of Critical Care, Peng and coworkers [1]
elegantly document a relatively low circulating cortisol res-
ponse to adrenocorticotropic hormone (ACTH) stimulation in
non-survivors (versus a normal response in survivors) of acute
biliary pancreatitis. This was associated with more frequent
bacteremia and severe disease. In fact, the ACTH-induced
cortisol response inversely related to disease severity
measures, as noted before [2]. None of the patients were
treated by adrenal substitution doses of corticosteroids, even
though often suffering from septic shock, as can be deduced
from the data, likely associated with infection of pancreatic
necrosis and subsequent bacteremia, as commonly occurs in
severe cases [3]. Hence, it was suggested that insufficient
adrenal cortisol secretion (reserve), relative to severity of
disease, contributed to a poor outcome, reflecting critical
illness-related corticosteroid insufficiency (CIRCI) even
though baseline cortisol values did not differ between
outcome groups.
Even though the recent Corticosteroid Therapy of Septic
Shock (CORTICUS) study [4] does not suggest either the
presence of CIRCI (as defined above) and a benefit of
corticosteroid treatment in (relatively mild) septic shock, the
concept can still not be refuted in view of a number of other
studies documenting the issues in more severe septic shock
[2,5,6]. Nevertheless, the question remains whether (septic)
shock originating from pancreatitis would manifest differently
than septic shock from other origins, and, thus, whether
shock originating from pancreatitis would similarly benefit
from corticosteroid treatment. To prove the latter, studies
including large numbers of subjects are probably needed, so
a definitive answer is unlikely to be provided in the near
future. Therefore, current practise recommendations can only
be based on the literature on ‘general’ septic shock, and
substitution doses of corticosteroids are still considered
useful in the early treatment of the syndrome according to a
recent metaanalysis [6], particularly when associated with
relatively low ACTH-induced cortisol responses [2] and in
spite of the negative CORTICUS trial [4,5].
A current study on pancreatitis [1] is also in line with the
observed adrenal enlargement, probably caused by increased
blood flow and haemorrhage/necrosis following intense
stress-induced stimulation during acute pancreatitis, the
exhausted secretion reserve upon ACTH stimulation noted
before in pancreatic necrosis/infection associated with
severe disease and non-survival, and the positive haemo-
dynamic effects of substitution doses of corticosteroids, even
in the absence of documented infection, reported by others
[7-11]. Indeed, a direct role for CIRCI in contributing to
pancreatic necrosis has been suggested [8,10]. Finally, there
is experimental evidence for adrenal changes during pancrea-
titis, a role for phospholipase A2 in this condition and the
benefit of low-dose cortisol administration in the development
and ultimate outcome of necrosis [1,10,12,13]. However, we
can not determine the cause and effect relationships from the
associations reported by Peng and coworkers [9], since the
independent predictive value for mortality of ACTH-induced
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cortisol responses was not studied. Such predictive value,
independent of other markers of disease severity, would
indeed argue in favour of a contributory role of CIRCI in
outcome and treatment by substitution doses of cortico-
steroids. Moreover, optimal cutoff levels in ACTH-induced
cortisol responses with the highest predictive values for
outcome are missing, and the increase of <250 nmol/l
(9 mg/dL), found to discriminate in other studies [4,6,10], was
used as the cutoff to denote CIRCI, even though it is
dependent, almost by definition, on the severity of disease [2].
Notwithstanding some limitations, the study in Critical Care
by Peng and coworkers [1] supports the idea that acute
(necrotic/infected) pancreatitis can result in CIRCI following
relative adrenal insufficiency, that the ACTH test can help to
recognise it, and that the condition likely warrants treatment
with substitution doses of corticosteroids. More data are
welcome that can be included in a systematic analysis to
confirm these ideas.
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